Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Observational Prospective Cohort Study to Assess the Safety of Vivotif at Different Release Titers Among Travelers

NCT02391909 is registered in ClinicalTrials.gov with Bavarian Nordic as lead sponsor.

NCT NCT02391909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02391909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Observational Prospective Cohort Study to Assess the Safety of Vivotif at Different Release Titers Among Travelers
Lead sponsor
Bavarian Nordic
Phase
Observational
Overall status
Completed
Start date
August 26, 2015
Completion date
February 21, 2017
Enrollment
855 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

typhoid fever